The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
Teva Pharmaceuticals TEVA-0.81%decrease; red down pointing triangle will pay $450 million to resolve allegations that ... Department on Thursday said the settlement amount was based on the company ...
Teva Pharmaceuticals has agreed to pay $425 million to resolve allegations that the company ... submission of false claims to Medicare. 2. The settlement was reached after the government's review ...
(RTTNews) - Teva Pharmaceuticals (TEVA) has agreed to pay $450 million in a settlement under the False Claims Act to resolve allegations related to kickbacks concerning copayments and price fixing ...
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
Attorney General Charity Clark announced two significant multistate settlements with Heritage Pharmaceuticals and Apotex which nationally total $49.1 million. The settlements resolve allegations that ...
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
As part of the settlement, there was no admission ... the department said. Separately, Teva agreed to resolve allegations that it conspired with other generic drug manufacturers to fix prices ...